Journal article icon

Journal article

Relationship Between Coronavirus Disease 2019 Vaccination Rates and Rare But Potentially Fatal Adverse Events: A Regression Discontinuity Analysis of Western Countries

Abstract:
BACKGROUND: Owing to limited experience with the new vaccine platforms, discussion of vaccine safety is inevitable. However, media coverage of adverse events of special interest could influence the vaccination rate; thus, evaluating the outcomes of adverse events of special interest influencing vaccine administration is crucial. METHODS: We conducted regression discontinuity in time analysis to calculate the local average treatment effect (LATE) using datasets from Our World in Data and Johns Hopkins University Center for Systems Science and Engineering. For the United States, the United Kingdom, and Europe, the cutoff points were April 23rd and June 23rd, April 7th, and the 14th week of 2021, respectively. RESULTS: The LATE of the Advisory Committee on Immunization Practices (ACIP) meeting held on April 23rd was -0.249 for all vaccines, -0.133 (-0.189 to -0.076) for Pfizer, -0.064 (-0.115 to -0.012) for Moderna, and -0.038 (-0.047 to -0.030) for Johnson & Johnson. Discontinuities were observed for all three types of vaccines in the United States. The June 23rd meeting of the ACIP (mRNA vaccines and myocarditis) did not convene any discontinuities. Furthermore, there was no significant drop in the weekly average vaccination rates in Europe following the European Medicines Agency (EMA) statement on April 7th. Conversely, there was a significant drop in the first-dose vaccination rates in the United Kingdom related to the EMA report. The first-dose vaccination rate for all vaccines changed by -0.104 (-0.176 to -0.032). CONCLUSION: Although monitoring and reporting of adverse events of special interest are important, a careful approach towards public announcements is warranted.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.3346/jkms.2023.38.e94

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-8250-8366
More by this author
Role:
Author
ORCID:
0000-0002-5523-5144
More by this author
Role:
Author
ORCID:
0000-0003-4968-5031
More by this author
Role:
Author
ORCID:
0000-0003-4965-872X
More by this author
Role:
Author
ORCID:
0000-0002-4856-3668


More from this funder
Funder identifier:
10.13039/501100003569
Grant:
22183MFDS431
More from this funder
Funder identifier:
10.13039/501100006107
Grant:
2019-11
More from this funder
Funder identifier:
10.13039/501100003725
Grant:
NRF-2021R1A5A2030333


Publisher:
Korean Academy of Medical Sciences
Journal:
Journal of Korean Medical Science More from this journal
Volume:
38
Issue:
11
Pages:
e94-e94
Article number:
e94
Publication date:
2023-01-01
DOI:
EISSN:
1598-6357
ISSN:
1011-8934


Language:
English
Keywords:
Pubs id:
1334125
Local pid:
pubs:1334125
Source identifiers:
W4324009100
Deposit date:
2026-05-05
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP